Health Care & Life Sciences » Biotechnology | Shanghai RAAS Blood Products Co. Ltd.

Shanghai RAAS Blood Products Co. Ltd. | Mutual Funds

Mutual Funds that own Shanghai RAAS Blood Products Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
4,338,759
0%
-1,088,900
0%
12/31/2017
Huatai - PineBridge CSI 300 ETF Units
2,554,595
0%
676,720
0%
12/31/2017
China AMC CSI 300 Index ETF (CN)
2,331,802
0%
750,344
0%
12/31/2017
Harvest SZSE SME-CHINEXT 300 ETF
2,319,702
0%
620,640
0%
12/31/2017
China SME ETF
1,832,911
0%
509,400
0%
12/31/2017
1,778,129
0%
67,155
0%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
1,704,422
0%
0
0%
07/31/2018
Rongtong Shenzhen 100 Index Fund
1,588,699
0%
-273,000
0%
06/30/2017
E Fund Shenzhen SI100 ETF
1,494,838
0%
504,440
0%
12/31/2017
ChinaAMC ETF Series - CSI 300 Index ETF
1,400,151
0%
-900
0%
12/31/2017

About Shanghai RAAS Blood Products Co.

View Profile
Address
No. 2009 Wangyuan Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.raas-corp.com
Updated 07/08/2019
Shanghai RAAS Blood Products Co., Ltd. engages in the production and sale of blood products. It provides testing services for blood, vaccines, diagnostic reagents, and testing equipment. Its products include human albumin, human intravenous immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, human fibrinogen, human thrombin and human fibrin sealant, human immunoglobulin, hepatitis B immunoglobulin, tetanus immunoglobulin, and rabies immunoglobulin.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.